Article History
Accepted: 26 April 2021
First Online: 21 May 2021
Disclosures
: L. Palaniyappan reports personal fees from Janssen Canada, Otsuka Canada, SPMM Course Limited, UK, and the Canadian Psychiatric Association; book royalties from Oxford University Press; investigator-initiated educational grants from Sunovion, Janssen Canada and Otsuka Canada; and travel support from Boehringer Ingelheim and Magstim Limited, outside the submitted work. In the last 5 years, L. Palaniyappan and/or his spouse have held shares in Shire Pharmaceuticals and GlaxoSmithKline in their pension funds for values less than US$10000. The other authors reported no potential conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.